Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13858)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
May 7, 2020 (publication date) through Nov 4, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Katsarou A, Moustakas II, Pyrina I, Lembessis P, Koutsilieris M, Chatzigeorgiou A. Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease. World J Gastroenterol 2020; 26(17): 1993-2011 [PMID: 32536770 DOI: 10.3748/wjg.v26.i17.1993] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8454/full/v26/i17/1993.htm |
| Number | Citing Articles |
| 1 |
Ioannis I. Moustakas, Angeliki Katsarou, Aigli-Ioanna Legaki, Iryna Pyrina, Konstantinos Ntostoglou, Alkistis-Maria Papatheodoridi, Bettina Gercken, Ioannis S. Pateras, Vassilis G. Gorgoulis, Michael Koutsilieris, Triantafyllos Chavakis, Antonios Chatzigeorgiou. Hepatic Senescence Accompanies the Development of NAFLD in Non-Aged Mice Independently of Obesity. International Journal of Molecular Sciences 2021; 22(7): 3446 doi: 10.3390/ijms22073446
|
| 2 |
Dmitry Victorovich Garbuzenko. Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis . World Journal of Clinical Cases 2022; 10(12): 3662-3676 doi: 10.12998/wjcc.v10.i12.3662
|
| 3 |
María E. Casado, Roberto Collado-Pérez, Laura M. Frago, Vicente Barrios. Recent Advances in the Knowledge of the Mechanisms of Leptin Physiology and Actions in Neurological and Metabolic Pathologies. International Journal of Molecular Sciences 2023; 24(2): 1422 doi: 10.3390/ijms24021422
|
| 4 |
Yu Wang, Geng Wang, Jie Bai, Ning Zhao, Qingbo Wang, Rui Zhou, Gang Li, Chaojie Hu, Xin Li, Kaixiong Tao, Zefeng Xia, Guobin Wang. Role of Indole-3-Acetic Acid in NAFLD Amelioration After Sleeve Gastrectomy. Obesity Surgery 2021; 31(7): 3040 doi: 10.1007/s11695-021-05321-0
|
| 5 |
Thanita Thongtan, Anasua Deb, Wasawat Vutthikraivit, Passisd Laoveeravat, Thammasak Mingbunjerdsuk, Sameer Islam, Ebtesam Islam. Antiplatelet therapy associated with lower prevalence of advanced liver fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis. Indian Journal of Gastroenterology 2022; 41(2): 119 doi: 10.1007/s12664-021-01230-3
|
| 6 |
Cuiling Zhu, Dongdong Huang, Huihui Ma, Chunhua Qian, Hui You, Le Bu, Shen Qu. High-Sensitive CRP Correlates With the Severity of Liver Steatosis and Fibrosis in Obese Patients With Metabolic Dysfunction Associated Fatty Liver Disease. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.848937
|
| 7 |
Kyoung-Jin Chung, Aigli-Ioanna Legaki, Grigorios Papadopoulos, Bettina Gercken, Janine Gebler, Robert F. Schwabe, Triantafyllos Chavakis, Antonios Chatzigeorgiou. Analysis of the Role of Stellate Cell VCAM-1 in NASH Models in Mice. International Journal of Molecular Sciences 2023; 24(5): 4813 doi: 10.3390/ijms24054813
|
| 8 |
Inês Sousa-Lima, Hyun Jeong Kim, John Jones, Young-Bum Kim. Rho-Kinase as a Therapeutic Target for Nonalcoholic Fatty Liver Diseases. Diabetes & Metabolism Journal 2021; 45(5): 655 doi: 10.4093/dmj.2021.0197
|
| 9 |
Weiwei Zhu, Namood E Sahar, Hafiz Muhammad Ahmad Javaid, Eun Seon Pak, Guang Liang, Yi Wang, Hunjoo Ha, Joo Young Huh. Exercise-Induced Irisin Decreases Inflammation and Improves NAFLD by Competitive Binding with MD2. Cells 2021; 10(12): 3306 doi: 10.3390/cells10123306
|
| 10 |
Juan He, Xin Zhang, Xi Chen, Zongyao Xu, Xiaoqi Chen, Jiangyan Xu. Shared Genes and Molecular Mechanisms between Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma Established by WGCNA Analysis. Global Medical Genetics 2023; 10(03): 144 doi: 10.1055/s-0043-1768957
|
| 11 |
Ratika Sehgal, Mariana Ilha, Maija Vaittinen, Dorota Kaminska, Ville Männistö, Vesa Kärjä, Marjo Tuomainen, Kati Hanhineva, Stefano Romeo, Päivi Pajukanta, Jussi Pihlajamäki, Vanessa D. de Mello. Indole-3-Propionic Acid, a Gut-Derived Tryptophan Metabolite, Associates with Hepatic Fibrosis. Nutrients 2021; 13(10): 3509 doi: 10.3390/nu13103509
|
| 12 |
Xiaohan Wang, Feng Han, Yueyu Shen, Yunqing Chen, Zizhong Ji. A20 Attenuates Lipopolysaccharide-Induced Inflammation Through MAPK/ERK/JNK Pathway in LX-2 Cells. Hepatitis Monthly 2021; 21(4) doi: 10.5812/hepatmon.114050
|
| 13 |
Tao Zhang, Yingli Nie, Jiliang Wang. The emerging significance of mitochondrial targeted strategies in NAFLD treatment. Life Sciences 2023; 329: 121943 doi: 10.1016/j.lfs.2023.121943
|
| 14 |
Jin Yan, Zijia Zhao, Min Xia, Shuya Chen, Xiancheng Wan, Anfei He, Guangyao Daniel Sheng, Xuedong Wang, Qiuhui Qian, Huili Wang. Induction of lipid metabolism dysfunction, oxidative stress and inflammation response by tris(1-chloro-2-propyl)phosphate in larval/adult zebrafish. Environment International 2022; 160: 107081 doi: 10.1016/j.envint.2022.107081
|
| 15 |
David Uihwan Lee, Reid Ponder, Ki Jung Lee, Harrison Chou, Keeseok Lee, Daniel Jung, Gregory Hongyuan Fan, Nathalie Helen Urrunaga. The prognostic relationship between donor age and infectious risk in liver transplant patients with nonalcoholic steatohepatitis: Analysis of UNOS database. Digestive and Liver Disease 2023; 55(6): 751 doi: 10.1016/j.dld.2023.01.160
|
| 16 |
Yun Shen, Yaxin Wang, Jingyi Lu, Yifei Mo, Xiaojing Ma, Gang Hu, Jian Zhou. Habitual use of glucosamine and adverse liver outcomes among patients with type 2 diabetes and MASLD. Liver International 2024; 44(9): 2359 doi: 10.1111/liv.16001
|
| 17 |
Grigorios Papadopoulos, Aigli-Ioanna Legaki, Konstantina Georgila, Panagiotis Vorkas, Eirini Giannousi, George Stamatakis, Ioannis I. Moustakas, Maria Petrocheilou, Iryna Pyrina, Bettina Gercken, Eva Kassi, Triantafyllos Chavakis, Ioannis S. Pateras, George Panayotou, Helen Gika, Martina Samiotaki, Aristides G. Eliopoulos, Antonios Chatzigeorgiou. Integrated omics analysis for characterization of the contribution of high fructose corn syrup to non-alcoholic fatty liver disease in obesity. Metabolism 2023; 144: 155552 doi: 10.1016/j.metabol.2023.155552
|
| 18 |
Maryam K. Ibrahim, Robert M. Wilechansky, Prasanna K. Challa, Xuehong Zhang, Edward Giovannucci, Meir Stampfer, Andrew T. Chan, Tracey G. Simon. The empirical dietary inflammatory pattern score and the risk of nonalcoholic fatty liver disease and cirrhosis. Hepatology Communications 2023; 7(10) doi: 10.1097/HC9.0000000000000263
|
| 19 |
Lampros Chrysavgis, Grigorios Papadopoulos, Antonios Chatzigeorgiou. Hepatobiliary Cancers: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2022; 3: 167 doi: 10.1007/16833_2022_87
|
| 20 |
Marta Szydlowska, Ginger Lasky, Stephanie Oldham, Cristian Rivera, Michael Ford, Bret R. Sellman, Christopher J. Rhodes, Taylor S. Cohen. Restoring polyamine levels by supplementation of spermidine modulates hepatic immune landscape in murine model of NASH. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2023; 1869(6): 166697 doi: 10.1016/j.bbadis.2023.166697
|
| 21 |
Qi Liu, Chengqian Lv, Yanan Jiang, Kunpeng Luo, Yang Gao, Jingyang Liu, Xu Zhang, Jan Mohammad Omar, Shizhu Jin. From hair to liver: emerging application of hair follicle mesenchymal stem cell transplantation reverses liver cirrhosis by blocking the TGF-β/Smad signaling pathway to inhibit pathological HSC activation. PeerJ 2022; 10: e12872 doi: 10.7717/peerj.12872
|
| 22 |
Weixiong Zhu, Chuanlei Fan, Shi Dong, Xin Li, Haofei Chen, Wence Zhou. Neutrophil extracellular traps regulating tumorimmunity in hepatocellular carcinoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1253964
|
| 23 |
Haoqi Chen, Xiaolong Chen, Genshu Wang. Platelets: A review of their function and effects in liver diseases. Liver Research 2020; 4(3): 129 doi: 10.1016/j.livres.2020.08.002
|
| 24 |
Anwesha Gangopadhyay, Radwa Ibrahim, Karli Theberge, Meghan May, Karen L. Houseknecht. Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines. Frontiers in Neuroscience 2022; 16 doi: 10.3389/fnins.2022.1042442
|
| 25 |
Yaning Biao, Dantong Li, Yixin Zhang, Jingmiao Gao, Yi Xiao, Zehe Yu, Li Li, Yu-Chen Fan. Wulingsan Alleviates MAFLD by Activating Autophagy via Regulating the AMPK/mTOR/ULK1 Signaling Pathway. Canadian Journal of Gastroenterology and Hepatology 2024; 2024(1) doi: 10.1155/2024/9777866
|
| 26 |
Sharon O. Jensen-Cody, Matthew J. Potthoff. Hepatokines and metabolism: Deciphering communication from the liver. Molecular Metabolism 2021; 44: 101138 doi: 10.1016/j.molmet.2020.101138
|
| 27 |
Lampros Chrysavgis, Alkistis Papatheodoridi, Evangelos Cholongitas, Michael Koutsilieris, George Papatheodoridis, Antonios Chatzigeorgiou. Significance of Circulating Cell-Free DNA Species in Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2021; 22(16): 8849 doi: 10.3390/ijms22168849
|
| 28 |
Dimitrios Voudouris, Maria Horianopoulou, Zoi Apostolopoulou, Costas Chryssanthopoulos, Mari Bardopoulou, Maria Maridaki, Theodoros Vassilakopoulos, Michael Koutsilieris, Anastassios Philippou. The Effects of a Short-Term Combined Exercise Program on Liver Steatosis Indices and the Lipidemic and Glycemic Profile in NAFLD Individuals: A Pilot Study. Metabolites 2023; 13(10): 1074 doi: 10.3390/metabo13101074
|
| 29 |
Rallia-Iliana Velliou, Aigli-Ioanna Legaki, Polyxeni Nikolakopoulou, Nikolaos I. Vlachogiannis, Antonios Chatzigeorgiou. Liver endothelial cells in NAFLD and transition to NASH and HCC. Cellular and Molecular Life Sciences 2023; 80(11) doi: 10.1007/s00018-023-04966-7
|
| 30 |
Shudi Li, Suling Li, Fei Duan, Baoping Lu. Depression and NAFLD risk: A meta-analysis and Mendelian randomization study. Journal of Affective Disorders 2024; 352: 379 doi: 10.1016/j.jad.2024.02.074
|
| 31 |
Qin Ni, Chunfang Cai, Shengjie Ren, Junbiao Zhang, Yijun Zhao, Xinyi Wei, Yiyang Ge, Chengrui Wang, Wenjian Li, Ping Wu, Yuantu Ye, Xiamin Cao.
Pectin and soybean meal induce stronger inflammatory responses and dysregulation of bile acid (BA) homeostasis than cellulose and cottonseed meal, respectively, in largemouth bass (
Micropterus salmoides
), which might be attributed to their BA binding capacity
. Aquaculture Research 2021; 52(7): 2963 doi: 10.1111/are.15140
|
| 32 |
Ruojia Ma, Yike Zhan, Yamei Zhang, Liangan Wu, Xing Wang, Ming Guo. Schisandrin B ameliorates non‐alcoholic liver disease through anti‐inflammation activation in diabetic mice. Drug Development Research 2021; doi: 10.1002/ddr.21905
|
| 33 |
Aigli-Ioanna Legaki, Ioannis I. Moustakas, Michalina Sikorska, Grigorios Papadopoulos, Rallia-Iliana Velliou, Antonios Chatzigeorgiou. Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease. Current Obesity Reports 2022; 11(3): 126 doi: 10.1007/s13679-022-00473-1
|
| 34 |
Jessica Winarto, Dae-Geun Song, Cheol-Ho Pan. The Role of Fucoxanthin in Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2023; 24(9): 8203 doi: 10.3390/ijms24098203
|
| 35 |
Yanan Hao, Hanhan Fang, Xiaowei Yan, Wei Shen, Jing Liu, Pengfei Han, Yong Zhao, Weidong Zhang, Yanni Feng. Alginate Oligosaccharides Repair Liver Injury by Improving Anti-Inflammatory Capacity in a Busulfan-Induced Mouse Model. International Journal of Molecular Sciences 2023; 24(4): 3097 doi: 10.3390/ijms24043097
|
| 36 |
Alan Eduardo Botello-Manilla, Guillermo Nahúm López-Sánchez, Norberto Carlos Chávez-Tapia, Misael Uribe, Natalia Nuño-Lámbarri. Hepatic steatosis and respiratory diseases: a new panorama. Annals of Hepatology 2021; 24: 100320 doi: 10.1016/j.aohep.2021.100320
|
| 37 |
Chiara Compagnoni, Roberta Capelli, Veronica Zelli, Alessandra Corrente, Davide Vecchiotti, Irene Flati, Mauro Di Vito Nolfi, Adriano Angelucci, Edoardo Alesse, Francesca Zazzeroni, Alessandra Tessitore. MiR-182-5p Is Upregulated in Hepatic Tissues from a Diet-Induced NAFLD/NASH/HCC C57BL/6J Mouse Model and Modulates Cyld and Foxo1 Expression. International Journal of Molecular Sciences 2023; 24(11): 9239 doi: 10.3390/ijms24119239
|
| 38 |
Raquel Cano, José Pérez, Lissé Dávila, Ángel Ortega, Yosselin Gómez, Nereida Valero-Cedeño, Heliana Parra, Alexander Manzano, Teresa Véliz Castro, María Albornoz, Gabriel Cano, Joselyn Rojas-Quintero, Maricarmen Chacín, Valmore Bermúdez. Role of Endocrine-Disrupting Chemicals in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review. International Journal of Molecular Sciences 2021; 22(9): 4807 doi: 10.3390/ijms22094807
|
| 39 |
Amedeo Lonardo. Separating the apples from the oranges: from NAFLD heterogeneity to personalized medicine. Exploration of Medicine 2021; doi: 10.37349/emed.2021.00061
|
| 40 |
Mitsutaka Nakashima, Kazufumi Nakamura, Takahiro Nishihara, Keishi Ichikawa, Rie Nakayama, Yoichi Takaya, Norihisa Toh, Satoshi Akagi, Toru Miyoshi, Teiji Akagi, Hiroshi Ito. Association between Cardiovascular Disease and Liver Disease, from a Clinically Pragmatic Perspective as a Cardiologist. Nutrients 2023; 15(3): 748 doi: 10.3390/nu15030748
|
| 41 |
Yusuf Yilmaz, Christopher D. Byrne, Giovanni Musso. A single-letter change in an acronym: signals, reasons, promises, challenges, and steps ahead for moving from NAFLD to MAFLD. Expert Review of Gastroenterology & Hepatology 2021; 15(4): 345 doi: 10.1080/17474124.2021.1860019
|
| 42 |
Xin Tong, Li Lin, Peng Hu, Rui Cao, Yang Zhang, Joshua Olick‐Gibson, Lihong V. Wang. Non‐Invasive 3D Photoacoustic Tomography of Angiographic Anatomy and Hemodynamics of Fatty Livers in Rats. Advanced Science 2023; 10(2) doi: 10.1002/advs.202205759
|
| 43 |
Tu-Yung Chang, Shu-Hung Chang, Ying-Hsiu Lin, Wen-Chao Ho, Chiao-Yin Wang, Wen-Juei Jeng, Yung-Liang Wan, Po-Hsiang Tsui. Utility of quantitative ultrasound in community screening for hepatic steatosis. Ultrasonics 2021; 111: 106329 doi: 10.1016/j.ultras.2020.106329
|
| 44 |
Ya Xing, Cheng Xu, Xiao Lin, Minmeng Zhao, Daoqing Gong, Long Liu, Tuoyu Geng. Complement C3 participates in the development of goose fatty liver potentially by regulating the expression of FASN and ETNK1. Animal Science Journal 2021; 92(1) doi: 10.1111/asj.13527
|
| 45 |
Heng-Tong Han, Wei-Lin Jin, Xun Li. Mesenchymal stem cells-based therapy in liver diseases. Molecular Biomedicine 2022; 3(1) doi: 10.1186/s43556-022-00088-x
|
| 46 |
Mengfei Ning, Linfei Song, Xinyu Niu, Yiming Wang, Wenjie Liu, Jiaxiang Hu, Han Cai, Weitao Song, Long Liu, Huifang Li, Daoqing Gong, Jacqueline Smith, Yinhua Huang. Multiscale 3D genome organization underlies duck fatty liver with no adipose inflammation or serious injury. International Journal of Biological Macromolecules 2024; 271: 132452 doi: 10.1016/j.ijbiomac.2024.132452
|
| 47 |
Bahman Rostama, Megan Beauchemin, Celeste Bouchard, Elizabeth Bernier, Calvin P. H. Vary, Meghan May, Karen L. Houseknecht. Understanding Mechanisms Underlying Non-Alcoholic Fatty Liver Disease (NAFLD) in Mental Illness: Risperidone and Olanzapine Alter the Hepatic Proteomic Signature in Mice. International Journal of Molecular Sciences 2020; 21(24): 9362 doi: 10.3390/ijms21249362
|
| 48 |
Gideon G. Kang, Natalie L. Trevaskis, Andrew J. Murphy, Mark A. Febbraio. Diet-induced gut dysbiosis and inflammation: Key drivers of obesity-driven NASH. iScience 2023; 26(1): 105905 doi: 10.1016/j.isci.2022.105905
|
| 49 |
Juan Wan, Yanyan Zhang, Diqi Yang, Yongjie Liang, Ling Yang, Sha Hu, Zhen Liu, Qian Fang, Song Tian, Yi Ding. Gastrodin Improves Nonalcoholic Fatty Liver Disease Through Activation of the Adenosine Monophosphate–Activated Protein Kinase Signaling Pathway. Hepatology 2021; 74(6): 3074 doi: 10.1002/hep.32068
|
| 50 |
Nurainina Ayob, Khairul Najmi Muhammad Nawawi, Mohamad Hizami Mohamad Nor, Raja Affendi Raja Ali, Hajar Fauzan Ahmad, Seok Fang Oon, Norfilza Mohd Mokhtar. The Effects of Probiotics on Small Intestinal Microbiota Composition, Inflammatory Cytokines and Intestinal Permeability in Patients with Non-Alcoholic Fatty Liver Disease. Biomedicines 2023; 11(2): 640 doi: 10.3390/biomedicines11020640
|
| 51 |
Shiqing Li, Shengyi Lian, Wei Cheng, Tao Zhang, Xiaobing Gong. THE ROLE OF N6-METHYLADENOSINE METHYLTRANSFERASE RBM15 IN NONALCOHOLIC FATTY LIVER DISEASE. Shock 2024; 61(2): 311 doi: 10.1097/SHK.0000000000002294
|
| 52 |
Igor V. Maev, Alexey O. Bueverov, Artem V. Volnukhin. Efficacy and Safety of a Fixed Combination of Glycyrrhizic Acid and Essential Phospholipids in Non-Alcoholic Fatty and Alcoholic Liver Disease: Results from Randomized Placebo-Controlled Trials. Annals of the Russian academy of medical sciences 2021; 76(6): 595 doi: 10.15690/vramn1576
|
| 53 |
Manush Saydmohammed, Anupma Jha, Vineet Mahajan, Dillon Gavlock, Tong Ying Shun, Richard DeBiasio, Daniel Lefever, Xiang Li, Celeste Reese, Erin E Kershaw, Vijay Yechoor, Jaideep Behari, Alejandro Soto-Gutierrez, Larry Vernetti, Andrew Stern, Albert Gough, Mark T Miedel, D Lansing Taylor. Quantifying the progression of non-alcoholic fatty liver disease in human biomimetic liver microphysiology systems with fluorescent protein biosensors. Experimental Biology and Medicine 2021; 246(22): 2420 doi: 10.1177/15353702211009228
|
| 54 |
Cuiling Zhu, Huihui Ma, Dongdong Huang, Guifang Li, Jingyang Gao, Meili Cai, Hui You, Le Bu, Shen Qu. J-Shaped Relationship Between Serum Prolactin and Metabolic-Associated Fatty Liver Disease in Female Patients With Type 2 Diabetes. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.815995
|
| 55 |
Stanislav Konstantinovich Gruzdev, Irina Viktorovna Podoprigora, Oksana Anatolievna Gizinger. Immunology of gut microbiome and liver in non-alcoholic fatty liver disease (NAFLD): mechanisms, bacteria, and novel therapeutic targets. Archives of Microbiology 2024; 206(2) doi: 10.1007/s00203-023-03752-0
|
| 56 |
Wenju He, Qiang Xi, Huantian Cui, Pingping Zhang, Rui Huang, Taihuan Wang, Dongqiang Wang, B. O. Ajiboye. Liang‐Ge Decoction Ameliorates Coagulation Dysfunction in Cecal Ligation and Puncture‐Induced Sepsis Model Rats through Inhibiting PAD4‐Dependent Neutrophil Extracellular Trap Formation. Evidence-Based Complementary and Alternative Medicine 2023; 2023(1) doi: 10.1155/2023/5042953
|
| 57 |
Chao Han, Zongshuo Li, Ruiying Liu, Zihan Zhao, Yu Wang, Xuli Zuo, Yushi Zhang, Zeyu Geng, Houyu Huang, Xiuzhen Pan, Weidong Li. Lonicerae flos polysaccharides improve nonalcoholic fatty liver disease by activating the adenosine 5′‐monophosphate‐activated protein kinase pathway and reshaping gut microbiota. Journal of the Science of Food and Agriculture 2023; 103(15): 7721 doi: 10.1002/jsfa.12854
|
| 58 |
Siarhei A. Dabravolski, Evgeny E. Bezsonov, Mirza S. Baig, Tatyana V. Popkova, Alexander N. Orekhov. Mitochondrial Lipid Homeostasis at the Crossroads of Liver and Heart Diseases. International Journal of Molecular Sciences 2021; 22(13): 6949 doi: 10.3390/ijms22136949
|
| 59 |
Xiaofu Zhang, Ruyi Li, Yingjie Chen, Yuning Dai, Ling Chen, Lei Qin, Xingbo Cheng, Yan Lu. The Role of Thyroid Hormones and Autoantibodies in Metabolic Dysfunction Associated Fatty Liver Disease: TgAb May Be a Potential Protective Factor. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.598836
|
| 60 |
Ioannis S. Pateras, Ana Igea, Ilias P. Nikas, Danai Leventakou, Nektarios I. Koufopoulos, Argyro Ioanna Ieronimaki, Anna Bergonzini, Han Suk Ryu, Antonios Chatzigeorgiou, Teresa Frisan, Christos Kittas, Ioannis G. Panayiotides. Diagnostic Challenges during Inflammation and Cancer: Current Biomarkers and Future Perspectives in Navigating through the Minefield of Reactive versus Dysplastic and Cancerous Lesions in the Digestive System. International Journal of Molecular Sciences 2024; 25(2): 1251 doi: 10.3390/ijms25021251
|
| 61 |
Jinkyung Cho, Bruce D. Johnson, Kymberly D. Watt, Alexander S. Niven, Dongwook Yeo, Chul-Ho Kim. Exercise training attenuates pulmonary inflammation and mitochondrial dysfunction in a mouse model of high-fat high-carbohydrate-induced NAFLD. BMC Medicine 2022; 20(1) doi: 10.1186/s12916-022-02629-1
|
| 62 |
Joeri Lambrecht, Frank Tacke. Controversies and Opportunities in the Use of Inflammatory Markers for Diagnosis or Risk Prediction in Fatty Liver Disease. Frontiers in Immunology 2021; 11 doi: 10.3389/fimmu.2020.634409
|
| 63 |
Liping Xiang, Yang Jiao, Yiling Qian, Yao Li, Fei Mao, Yan Lu. Comparison of hepatic gene expression profiles between three mouse models of Nonalcoholic Fatty Liver Disease. Genes & Diseases 2022; 9(1): 201 doi: 10.1016/j.gendis.2021.02.008
|
| 64 |
Marina Nati, Kyoung-Jin Chung, Triantafyllos Chavakis. The Role of Innate Immune Cells in Nonalcoholic Fatty Liver Disease. Journal of Innate Immunity 2022; 14(1): 31 doi: 10.1159/000518407
|
| 65 |
Angeliki Katsarou, Georgios Tsioulos, Eva Kassi, Antonios Chatzigeorgiou. Current and experimental pharmacotherapy for the management of non-alcoholic fatty liver disease. Hormones 2024; 23(4): 621 doi: 10.1007/s42000-024-00588-1
|
| 66 |
Pallavi Subramanian, Jochen Hampe, Frank Tacke, Triantafyllos Chavakis. Fibrogenic Pathways in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD). International Journal of Molecular Sciences 2022; 23(13): 6996 doi: 10.3390/ijms23136996
|
| 67 |
Hans A. R. Bluyssen, Antonios Chatzigeorgiou. Editorial: Updates on innate immune responses in hepatic health and disease. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1190405
|
| 68 |
Charlotte Teunis, Max Nieuwdorp, Nordin Hanssen. Interactions between Tryptophan Metabolism, the Gut Microbiome and the Immune System as Potential Drivers of Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolic Diseases. Metabolites 2022; 12(6): 514 doi: 10.3390/metabo12060514
|
| 69 |
Jyoti Chhimwal, Abhishek Goel, Mahesh Sukapaka, Vikram Patial, Yogendra Padwad. Phloretin mitigates oxidative injury, inflammation, and fibrogenic responses via restoration of autophagic flux in in vitro and preclinical models of NAFLD. The Journal of Nutritional Biochemistry 2022; 107: 109062 doi: 10.1016/j.jnutbio.2022.109062
|